AjeyoLAST UPDATED: July 22, 2020, 2:20 p.m.
New Delhi: Even as the coronavirus pandemic creates havoc all around the world, scientists in several countries are working hard to come up with a COVID-19 vaccine.
The coronavirus vaccine named 'Covishield' is expected to be available within a few months in India. Its price in India is likely to be around 1000 rupees.
Britain's Oxford University has come up a coronavirus vaccine named 'AstraZeneco' which saw the Serum Institute of India play an important role during its research stage.
Vaccine will come next year
The Oxford University claims that its coronavirus vaccine will have no side effects. This COVID-19 vaccine will be launched in India under the name 'Covishield' in collaboration with Serum Institute of India.
The Serum Institute of India has pledged to make one billion doses of the COVID-19 vaccine jointly with Oxford-AstraZeneca. The company has already said that human trials in India will start next month, while production could start in the first quarter early next year.
Price will be less than 1000 rupees
In an interview to New Indian Express, Serum Institute of India CEO Adar Poonawala said that this coronavirus vaccine will be provided to people at a price less than Rs 1,000.
"We will keep the price below Rs. 1,000. Our objective is to provide an effective and affordable vaccine. We are sure that it will be bought and distributed by the government," Poonawala said.
"Of course it will be given out at a very affordable price. Today, a COVID-19 test incurs Rs 2,500. There are drugs like Remdesiver that are costing tens and thousands of rupees. We are planning to put the price at around Rs 1,000 or less than that per dose. I don't think any individual will have to pay for it because the vaccines will mostly be bought by governments and then distributed free through the immunisation programmes," he was quoted as saying by India Today.
"I don't see any citizen having to pay for this vaccine... or at least they should not. It is a national security issue and the government must put in its efforts, and they are doing it."
Oxford University and AstraZeneca have released data for early trials of the coronavirus vaccine which is now in its third phase of testing. Several other coronavirus vaccine candidates are engaged in testing in India and worldwide.